Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...
The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two decades. Historically, therapeutic strategies primarily focused on suppressing ...
Abstract: In an era marked by the swift progress of technology, Cyber-Physical Systems (CPS) conquer one of the top places, standing out through the ability to integrate physical components and ...
Abstract: With the increasing complexity of aircraft, document-based systems engineering has gradually become inadequate, and model-based systems engineering has become a hot issue in the aviation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback